These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1682345)

  • 1. Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.
    Holodniy M; Katzenstein DA; Israelski DM; Merigan TC
    J Clin Invest; 1991 Nov; 88(5):1755-9. PubMed ID: 1682345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of human immunodeficiency virus by culture and polymerase chain reaction in response to didanosine after long-term therapy with zidovudine.
    Katzenstein DA; Winters M; Bubp J; Israelski D; Winger E; Merigan TC
    J Infect Dis; 1994 Feb; 169(2):416-9. PubMed ID: 7906292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reaction.
    Lu W; Andrieu JM
    J Infect Dis; 1993 May; 167(5):1014-20. PubMed ID: 7683705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment.
    Stellbrink HJ; Zöller B; Fenner T; Lichtenberg G; van Lunzen J; Albrecht H; Thiele HG; Greten H
    AIDS; 1996 Jul; 10(8):849-57. PubMed ID: 8828742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy.
    Andreoni M; Sarmati L; Ercoli L; Nicastri E; Giannini G; Galluzzo C; Pirillo MF; Vella S
    AIDS Res Hum Retroviruses; 1997 May; 13(7):555-61. PubMed ID: 9135873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.
    Holodniy M; Katzenstein D; Winters M; Montoya J; Shafer R; Kozal M; Ragni M; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):366-9. PubMed ID: 8095981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy.
    Hamed KA; Winters MA; Holodniy M; Katzenstein DA; Merigan TC
    J Infect Dis; 1993 Apr; 167(4):798-802. PubMed ID: 8450243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administration.
    Clark AG; Holodniy M; Schwartz DH; Katzenstein DA; Merigan TC
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):52-9. PubMed ID: 1738087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
    Ibáñez A; Peraire J; Arnó A; Gutiérrez C; Cervantes M; Colomer J; Villalonga C; Camafort M; Ruiz L; Balaguer M; Vidal F; Richart C; Clotet B
    Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction.
    Winters MA; Tan LB; Katzenstein DA; Merigan TC
    J Clin Microbiol; 1993 Nov; 31(11):2960-6. PubMed ID: 7903317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
    JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.
    Aoki-Sei S; Yarchoan R; Kageyama S; Hoekzema DT; Pluda JM; Wyvill KM; Broder S; Mitsuya H
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1263-70. PubMed ID: 1520538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
    Jackson JB
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of HIV-1 viral sequences detected by the polymerase chain reaction in haemophilic patients to clinical and other markers of infection.
    Dannatt AH; Goodwin SJ; Dasani H; Bowen DJ; Peake IR; Bloom AL
    Clin Lab Haematol; 1992; 14(1):1-7. PubMed ID: 1350951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction.
    Holodniy M; Katzenstein DA; Sengupta S; Wang AM; Casipit C; Schwartz DH; Konrad M; Groves E; Merigan TC
    J Infect Dis; 1991 Apr; 163(4):862-6. PubMed ID: 2010639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.